Abstract Bispecific T cell engagers (BiTEs) are an innovative class of immunotherapeutics that redirect T cells to tumor surface antigens. While efficacious against certain hematological malignancies. limited bioavailability and severe toxicities have so far hampered broader clinical application. especially against solid tumors. https://www.nacrack.com/deal-alert-Dea-Eyewear-Jemma-deal-zone/